Patients With Cancer Who Die at Home Experience Similar, Longer Survival

Share this content:
For cancer patients, survival is similar or longer for those who die at home versus those who die in the hospital.
For cancer patients, survival is similar or longer for those who die at home versus those who die in the hospital.

For cancer patients, survival is similar or longer for those who die at home versus those who die in the hospital, according to a study published in Cancer.

Jun Hamano, M.D., from the University of Tsukuba in Japan, and colleagues conducted a multicenter prospective cohort study to examine potential differences in survival time for cancer patients dying at home or in a hospital. A total of 2,426 patients were recruited and 2,069 were analyzed (1,582 receiving hospital-based palliative care and 487 receiving home-based palliative care).

The researchers found that 1,607 patients actually died in a hospital and 462 died at home. Patients who died at home had significantly longer survival than those who died in a hospital in the days' prognosis group (estimated median survival time, 13 versus nine days; P = 0.006) and the weeks' prognosis group (36 versus 29 days; P = 0.007).

There was no significant difference between the groups in the months' prognosis group. In both unadjusted and adjusted models, place of death had a significant influence on the survival time (hazard ratios, 0.86 and 0.87, respectively).

RELATED: Cologuard At-Home Test Now Covered by Several Health Plans

"In conclusion, cancer patients who died at home had similar or longer survival in comparison with those who died in a hospital," the authors write.

Reference

  1. Hamano J, Yamaguchi T, Maeda I, et al. Multicenter cohort study on the survival time of cancer patients dying at home or in a hospital: Does place matter? [published online ahead of print March 29, 2016.] Cancer. DOI: 10.1002/cncr.29844.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs